Institutional Clinical and Translational Science Award

机构临床和转化科学奖

• 批准号: 9306973
• 负责人: Glen N. Gaulton
• 金额: $ 127.82万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-01 至 2021-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9306973
• 关键词: Area; Award; Awareness; Biography; Categories; Certification; Cities; Clinical; Clinical Sciences; Code; Collection; Country; County; Coupled; Development; Development Plans; Discipline; Doctor of Philosophy; Electronic Mail; Elements; Enrollment; Ethics; Eye; First Name; Funding Opportunities; Goals; Hour; Individual; Individuality; Institutes; Instruction; Knowledge; Last Name; Lead; Master' s Degree; Medicine; Mentors; Mentorship; Names; National Research Service Awards; Pathology; Pennsylvania; Persons; Phonation; Positioning Attribute; Postdoctoral Fellow; Principal Investigator; Professional Competence; Province; Recruitment Activity; Research; Resources; Role; Specific qualifier value; Structure; TNFSF15 gene; Talents; Telefacsimile; Telephone; Therapeutic; Time; Training; Training Programs; Translational Research; Translations; United States; Universities; arm; career; experience; expiration; flexibility; innovation; next generation; pre-doctoral; preference; programs; research facility; skills

Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (234) Core J: Institutional Training Core PROJECT SUMMARY/ABSTRACT The goal and significance of the University of Pennsylvania (Penn) TL1 proposal is matched to both a national and societal need to dramatically enhance clinical and translational science (CTS). A key component of this goal is to train the next generation of research leaders of this domain. As expressed throughout our CTSA proposal, Penn is committed “all-in” to the advancement of translational science, led by the Institute for Translation Medicine and Therapeutics (ITMAT), and within this to achieve the overarching TL1 goal of arming our trainees with the awareness, skills and resources that will position them to excel in the conduct of CTS. Ten pre-doctoral and ten post-doctoral slots are requested to support TL1 Scholars who will enroll in either Certificate (1year) or Master degree (2-3year) programs developed specifically for CTS. The structure of Penn's TL1 builds synergistically upon and integrates seamlessly with Penn's outstanding graduate and post- graduate programs, but recognizes that translational science requires a distinctive, additional knowledge and skill set. Pre-doctoral Scholars will be selected from Penn's PhD, MD/PhD and VMD/PhD research programs and MD, VMD, DMD and MNS clinical training programs. Similarly, post-doctoral Scholars will be selected from Penn's outstanding clinical (MD, VMD, DMD) residents and fellows, and research (PhD) fellows. The primary objectives of the TL1 program are: • Recruit talented and committed trainees by promoting awareness and individual assessment; • Develop mentored personalized trainee educational plans targeted both to discipline specific skills and professional competencies; • Develop fundamental scientific skills and conduct mentored research in clinical and translational science; • Advance training programs in emerging areas of translational science; • Augment aligned professional skill sets of trainees to bolster career progression Scholars are supported by innovative cross-discipline bridges, by creating new knowledge paradigms for translation, by providing outstanding translational research facilities and cores, and through active advising and mentorship – always with an eye toward the highest ethical standards, the essential tenants of translation, what unites our trainees as colleagues, and what distinguishes our training program and the TL1 award as a singular entity, rather than a mere collection of elements. The TL1 minimizes time-to-degree by effective use of elective units and off-hours online instruction. The TL1 emphasizes the development of individual professional development plans to support diverse career preferences. Importantly, the program is also coupled to a robust diversity and inclusion effort, and a dedicated mentoring program. In summary, Penn's TL1/CTSA approach speaks directly to each of the five key CTSA goals and builds upon existing excellence with rigor, breadth, flexibility and individuality. The educational program is led by talented and experienced Co-Program Directors and the TL1 award is seamlessly integrated with the CTSA-U and KL2 award components. Importantly, the TL1 award is the only dedicated mechanism at Penn to support pre and post-doctoral scholars in CTS. Project Summary/Abstract Page 1102 Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (234) OMB Number: 4040-0001 Expiration Date: 06/30/2016 RESEARCH & RELATED Senior/Key Person Profile (Expanded)   PROFILE - Project Director/Principal Investigator Prefix:  First Name*: Glen Middle Name N. Last Name*: Gaulton Suffix:  Position/Title*: PROFESSOR A Organization Name*: University of Pennsylvania Department: Division: Street1*: UNIVERSITY OF PENNSYLVANIA Street2: DEPT OF PATHOLOGY & LAB MEDICINE City*: PHILADELPHIA County: State*: PA: Pennsylvania Province: Country*: USA: UNITED STATES Zip / Postal Code*: 191046082 Phone Number*: (215) Fax Number: [phone] E-Mail*: [e-mail] 898-2874 Credential, e.g., agency login: gaulton Project Role*:  Other (Specify) Other Project Role Category: Core Lead Degree Type:  PHD,BS Degree Year:    File Name Mime Type Attach Biographical Sketch*: GaultonG_Biosketch_CTSA_2015.pdf application/pdf Attach Current & Pending Support:   Page 1103 Tracking Number: GRANT11998683 Funding Opportunity Number: PAR-15-304 . Received Date: 2015-09-24T11:44:37.000-04:00

联系 PD/PI：FITZGERALD、GARRET A NRSA-Training-001 (234) 核心 J：机构培训核心 项目概要/摘要 宾夕法尼亚大学 (Penn) TL1 提案的目标和意义与国家级 和社会需要大幅加强临床和转化科学（CTS），这是其中的一个关键组成部分。 正如我们的 CTSA 所表达的那样，我们的目标是培养该领域的下一代研究领导者。 根据提案，宾夕法尼亚大学致力于“全力以赴”推动由研究所领导的转化科学的进步 转化医学和治疗学 (ITMAT)，并在此范围内实现 TL1 的总体目标：武装 我们的学员所具备的意识、技能和资源将使他们能够在 CTS 的实施中表现出色。 需要 10 个博士前和 10 个博士后名额来支持 TL1 学者，他们将注册 专为 CTS 开发的证书（1 年）或硕士学位（2-3 年）课程的结构。 宾夕法尼亚大学的 TL1 与宾夕法尼亚大学杰出的毕业生和研究生协同构建并无缝集成。 研究生课程，但认识到转化科学需要独特的、额外的知识和 博士前学者将从宾夕法尼亚大学的博士、医学博士/博士和VMD/博士研究项目中选拔。 以及MD、VMD、DMD和MNS临床培训项目。博士后学者将同样选拔 来自宾夕法尼亚大学杰出的临床（MD、VMD、DMD）住院医师和研究员以及研究（博士）研究员。 TL1 计划的主要目标是： • 通过提高意识和个人评估来招募有才华和忠诚的学员； • 制定有指导的个性化学员教育计划，旨在培养特定技能和 专业能力； • 培养基本科学技能并进行临床和转化方面的指导研究 科学; • 推进转化科学新兴领域的培训计划； • 增强学员的专业技能，以促进职业发展 学者们得到创新的跨学科桥梁的支持，通过创建新的知识范式 翻译，通过提供出色的翻译研究设施和核心，并通过积极的建议和 指导——始终着眼于最高的道德标准，这是翻译的基本原则， 是什么让我们的学员成为同事，以及我们的培训计划和 TL1 奖作为 TL1 通过有效使用来最大限度地缩短达到学位所需的时间。 TL1 强调个人的发展。 重要的是，该计划还支持多样化的职业偏好。 再加上强大的多元化和包容性努力以及专门的指导计划。 总之，宾夕法尼亚大学的 TL1/CTSA 方法直接涉及五个关键 CTSA 目标中的每一个，并建立在 现有的卓越性具有严谨性、广度、灵活性和个性化。 和经验丰富的联合项目总监，TL1 奖项与 CTSA-U 和 KL2 无缝集成 重要的是，TL1 奖项是宾夕法尼亚大学唯一支持预科和预科的专门机制。 CTS博士后学者。 项目摘要/摘要第 1102 页 联系 PD/PI：FITZGERALD、GARRET A NRSA-Training-001 (234) OMB 编号：4040-0001 到期日期：2016 年 6 月 30 日 研究及相关高级/关键人物简介（扩展）   简介 - 项目总监/首席研究员 前缀： 名字*： Glen 中间名 N. 姓氏*： Gaulton 后缀： 职位/头衔*： A 教授 组织名称*：宾夕法尼亚大学 部门： 分配： 街道 1*: 宾夕法尼亚大学 Street2：病理学和实验室医学系 城市*: 费城 县： 州*：宾夕法尼亚州：宾夕法尼亚州 省： 国家*： 美国： 美国 邮政编码*：191046082 电话号码*：(215) 传真号码：[phone] 电子邮件*：[e-mail] 898-2874 凭据，例如机构登录名：gaulton 项目角色*：其他（请注明）其他项目角色类别：核心负责人 学位类型： 博士，学士学位 学位年份： ​ 文件名 Mime 类型 附上简历*：GaultonG_Biosketch_CTSA_2015.pdf 申请/pdf 附上当前和待定的支持：   第1103页 跟踪编号：GRANT11998683 资助机会编号：PAR-15-304 接收日期： 2015-09-24T11:44:37.000-04:00